Profound Medical (PROF) News
NASDAQ: PROFHealth CareMedical/Dental InstrumentsUSD
6.90-0.01 (-0.14%)
Market open · Delayed 15 min · as of Oct 9, 12:15 PM ET
PROF news summary
We found 3 recent headlines mentioning Profound Medical (PROF): 3 in the past week and 3 in the past 30 days, most often from GlobeNewswire, Nasdaq. For price context, PROF is down 0.14% at $6.90. The most recent story, "Profound Medical, Telix Pharma Sign Co-Education Deal To Advance PSMA-Informed Prostate Care", was published by Nasdaq on Oct 9, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest Profound Medical headlines
- Profound Medical, Telix Pharma Sign Co-Education Deal To Advance PSMA-Informed Prostate Care(RTTNews) - Friday, Profound Medical Corp. (PROF) and Telix Pharmaceuticals Limited (TLX) announced a co-education agreement to educate physicians and prostate cancer centers on the complementary…NasdaqPROF, TLX
- Profound Medical and Telix Pharmaceuticals Enter Co-Education Agreement to Advance PSMA-Informed Prostate CareCollaboration will educate physicians and prostate cancer centers on the complementary roles of Telix’s PSMA-PET molecular imaging technologies and Profound’s MRI-guided TULSA-PRO ®GlobeNewswirePRN, PROF
- Profound Medical Reports Strong Preliminary Third Quarter 2026 RevenueAnticipates Q3-2026 revenue of $9.8 million to $10.0 million, exceeding Bloomberg analyst consensus by approximately 45% to 47% Anticipates Q3-2026 revenue of $9.8 million to $10.0 million, exceeding…GlobeNewswirePRN, PROF